FDA-approved · BrandIllustration only. Actual medication will vary.Weight Management · FDA-approved oral GLP-1
Wegovy®
Tablets
Brand-name oral semaglutide from Novo Nordisk, taken once daily. Dispensed by a licensed U.S. pharmacy when a provider determines it is clinically appropriate.
Your Plan Options
1.5 mg / 4 mg
Starting strengths · 30 tabs/mo · 30-day supply
$339 /mo
1.5 mg / 4 mg
Starting strengths · 30 tabs/mo · 90-day supply
$959 /3 mo
Best value
9 mg / 25 mg
Higher strengths · 30 tabs/mo · 30-day supply
$519 /mo
9 mg / 25 mg
Higher strengths · 30 tabs/mo · 90-day supply
$1,479 /3 mo
Best value
No charge until a provider prescribes. Prescription required.
Clinical information
What this is, in plain language.
Wegovy® tablets contain semaglutide, a GLP-1 receptor agonist, in a once-daily oral form. This is an FDA-approved brand-name medication, dispensed by a licensed U.S. pharmacy only when a licensed provider determines it is clinically appropriate.
Active ingredients
Semaglutide (1.5, 4, 9 or 25 mg).
Mechanism
GLP-1 receptor agonist. Supports appetite regulation and glycemic response.
Administration
One tablet daily, taken as directed on the prescribing label. Strength stepped up under clinical guidance.
Who it is for
Adults who meet the prescribing criteria, when clinically appropriate.
Common effects
Nausea, diarrhea, vomiting, constipation. Discuss full risks, including the boxed warning, with your provider.
Important safety & compliance information
Wegovy® (semaglutide) tablets is an FDA-approved brand-name medication dispensed by a licensed U.S. pharmacy. Alexis is not affiliated with the manufacturer. Product imagery shown here is illustration only; actual medication is dispensed in a pharmacy-labeled container and will vary in appearance. A prescription is required and is issued only when a licensed provider determines treatment is clinically appropriate. This page is not medical advice. Discuss benefits, risks and side effects with your provider.